5.63
前日終値:
$5.62
開ける:
$5.67
24時間の取引高:
34,072
Relative Volume:
0.33
時価総額:
$66.36M
収益:
$52.29M
当期純損益:
$-73.52M
株価収益率:
-8.5303
EPS:
-0.66
ネットキャッシュフロー:
$-100.45M
1週間 パフォーマンス:
-0.71%
1か月 パフォーマンス:
+22.13%
6か月 パフォーマンス:
+27.95%
1年 パフォーマンス:
-36.88%
Precision Biosciences Inc Stock (DTIL) Company Profile
名前
Precision Biosciences Inc
セクター
電話
919-314-5512
住所
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
DTIL
Precision Biosciences Inc
|
5.63 | 66.24M | 52.29M | -73.52M | -100.45M | -0.66 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.07 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
472.17 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
551.61 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
809.47 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2024-04-30 | 開始されました | Guggenheim | Buy |
2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
2022-06-09 | ダウングレード | William Blair | Outperform → Mkt Perform |
2020-07-27 | 再開されました | BTIG Research | Buy |
2020-04-03 | ダウングレード | Goldman | Buy → Neutral |
2020-03-05 | 開始されました | Stifel | Buy |
2020-02-25 | 開始されました | William Blair | Outperform |
2019-08-09 | 開始されました | BTIG Research | Buy |
2019-07-16 | 開始されました | H.C. Wainwright | Buy |
2019-04-22 | 開始されました | Barclays | Overweight |
2019-04-22 | 開始されました | Goldman | Buy |
2019-04-22 | 開始されました | JP Morgan | Overweight |
2019-04-22 | 開始されました | Jefferies | Buy |
すべてを表示
Precision Biosciences Inc (DTIL) 最新ニュース
Is Precision BioSciences Inc. stock gaining market shareJuly 2025 Price Swings & Short-Term Swing Trade Alerts - newser.com
Has Precision BioSciences Inc. formed a bullish divergenceRate Cut & Consistent Growth Stock Picks - newser.com
Can Precision BioSciences Inc. stock resist market sell offsJuly 2025 Reactions & Technical Entry and Exit Alerts - newser.com
Why Precision BioSciences Inc. stock attracts high net worth investors2025 Big Picture & Safe Entry Zone Identification - newser.com
Is Precision BioSciences Inc. reversing from oversold territoryEarnings Summary Report & Consistent Income Trade Recommendations - newser.com
Precision BioSciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Key metrics from Precision BioSciences Inc.’s quarterly dataTrade Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
Is Precision BioSciences Inc. meeting your algorithmic filter criteriaQuarterly Growth Report & Community Driven Trade Alerts - newser.com
What high frequency data says about Precision BioSciences Inc.July 2025 Opening Moves & High Conviction Buy Zone Alerts - newser.com
Will Precision BioSciences Inc. stock gain from lower inflationPortfolio Value Report & Fast Moving Stock Trade Plans - newser.com
News impact scoring models applied to Precision BioSciences Inc.IPO Watch & Free Technical Pattern Based Buy Signals - newser.com
Using RSI to spot recovery in Precision BioSciences Inc.Market Movement Recap & AI Forecasted Entry and Exit Points - newser.com
Will Precision BioSciences Inc. stock recover faster than marketTrade Ideas & Weekly Hot Stock Watchlists - newser.com
What moving averages say about Precision BioSciences Inc.July 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for - PharmiWeb.com
Precision BioSciences (DTIL) Showcases Genomic Advances with ARC - GuruFocus
Precision BioSciences publishes research on ARCUS gene editing platform By Investing.com - Investing.com Canada
Relative strength of Precision BioSciences Inc. in sector analysisWall Street Watch & Community Verified Swing Trade Signals - newser.com
Precision BioSciences Announces Publication in Nucleic Acids Research Elucidating the Mechanisms for High Efficiency Gene Insertion in Dividing and Non-Dividing Cells Using ARCUS Nucleases - The AI Journal
Best data tools to analyze Precision BioSciences Inc. stockMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Regression analysis insights on Precision BioSciences Inc. performanceJuly 2025 Macro Moves & High Return Trade Opportunity Guides - newser.com
Does Precision BioSciences Inc. qualify in momentum factor screeningWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidateJuly 2025 Movers & Safe Entry Point Identification - newser.com
Why retail investors pile into Precision BioSciences Inc. stock2025 Market Overview & Reliable Volume Spike Alerts - newser.com
Precision BioSciences (NASDAQ:DTIL) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - BioSpace
Precision Biosciences, Inc. Announces Opening of First Clinical Trial Site in U.S. for Eliminate-B Trial - MarketScreener
Precision BioSciences (DTIL) Commences U.S. Clinical Trial for P - GuruFocus
Automated trading signals detected on Precision BioSciences Inc.July 2025 Trends & Safe Entry Zone Tips - newser.com
Can Precision BioSciences Inc. (PBS0) stock hold up in economic slowdownPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com
What momentum indicators show for Precision BioSciences Inc. stockOptions Play & Verified Swing Trading Watchlist - newser.com
Order flow analysis tools used on Precision BioSciences Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
Can a trend reversal in Precision BioSciences Inc. lead to recoveryWeekly Investment Summary & Fast Exit and Entry Strategy Plans - newser.com
Why Precision BioSciences Inc. stock is rated strong buyTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-05 04:45:59 - newser.com
Why global investors buy Precision BioSciences Inc. (PBS0) stock2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com
Published on: 2025-10-03 06:51:55 - newser.com
How to integrate Precision BioSciences Inc. into portfolio analysis toolsQuarterly Risk Review & Daily Price Action Insights - newser.com
Is Precision BioSciences Inc. (PBS0) stock undervalued by metricsJuly 2025 Trends & High Conviction Trade Alerts - newser.com
Precision Biosciences Inc (DTIL) 財務データ
収益
当期純利益
現金流量
EPS
Precision Biosciences Inc (DTIL) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Brown Melinda | Director |
Sep 22 '25 |
Buy |
4.89 |
1,400 |
6,846 |
21,965 |
Kelly John Alexander | Chief Financial Officer |
Jul 03 '25 |
Sale |
4.26 |
14,827 |
63,163 |
73,485 |
大文字化:
|
ボリューム (24 時間):